VolitionRx recorded its first revenue from a CE Mark product in Europe on August 16, 2025.
1 report, 1 independent
Updated Aug 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
VolitionRx recorded its first revenue from a CE Mark product in Europe on August 16, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
VolitionRx (United Kingdom)
organization
Nothing else this week.
-
Europe
terrestrial continent located in north-western Eurasia
Related events
- H-Power plc received the Attestation of Conformity from TÜV SÜD, which is required for the company's products to be commercially sold in Europe under the CE Mark.
- Persistent Systems reported a revenue mix shift to 22% from Europe and completed the acquisition of Nagarro SE for €1.27 billion.
- Products launched in the market in Europe starting on July 1st.
- Sales grew 5% in the European segment for Thor Industries.
- Interface, Inc. reported its revenue breakdown for August 2026, noting that 29% of its revenue came from Europe, while 60% came from the Americas.
Coverage
Newest first; wire copies grouped- GuruFocus.comVolitionRX Ltd (VNRX) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Advances ... Revenue: Over $400,000 in Q2 2025; first half total revenue over $650,000, up 15% year-over-year. Ope